| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |